Moise Anglade

2.1k total citations
10 papers, 273 citations indexed

About

Moise Anglade is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Moise Anglade has authored 10 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 3 papers in Economics and Econometrics and 1 paper in Surgery. Recurrent topics in Moise Anglade's work include Atrial Fibrillation Management and Outcomes (8 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Moise Anglade is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Moise Anglade collaborates with scholars based in United States. Moise Anglade's co-authors include Craig I Coleman, Jeffrey Kluger, Soyon Lee, C Michael White, William L. Baker, Erica L Baker, Diana M Sobieraj, Nitesh Sood and Christopher A. Clyne and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and European Journal of Cardio-Thoracic Surgery.

In The Last Decade

Moise Anglade

10 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moise Anglade United States 6 191 69 56 38 33 10 273
Miguel A. Sánchez-Zamorano Spain 11 179 0.9× 50 0.7× 29 0.5× 21 0.6× 140 4.2× 14 309
Miguel Ángel Prieto-Díaz Spain 10 178 0.9× 22 0.3× 18 0.3× 17 0.4× 36 1.1× 36 233
Thomas Andersen Rix Denmark 8 183 1.0× 14 0.2× 26 0.5× 58 1.5× 28 0.8× 12 332
Isabelle Gouin France 8 172 0.9× 26 0.4× 153 2.7× 7 0.2× 64 1.9× 17 283
Chrisly Dillon United States 9 162 0.8× 35 0.5× 52 0.9× 31 0.8× 67 2.0× 14 274
Alberto Calderón Spain 15 595 3.1× 41 0.6× 99 1.8× 39 1.0× 66 2.0× 41 644
Francisco Borrego Spain 10 282 1.5× 36 0.5× 89 1.6× 70 1.8× 108 3.3× 24 656
Jeroen Jaspers Focks Netherlands 7 193 1.0× 34 0.5× 54 1.0× 33 0.9× 39 1.2× 14 285
M.Á. Prieto Díaz Spain 10 169 0.9× 27 0.4× 9 0.2× 20 0.5× 56 1.7× 30 276
Irfan Shukrullah United States 6 221 1.2× 11 0.2× 14 0.3× 31 0.8× 57 1.7× 9 355

Countries citing papers authored by Moise Anglade

Since Specialization
Citations

This map shows the geographic impact of Moise Anglade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moise Anglade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moise Anglade more than expected).

Fields of papers citing papers by Moise Anglade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moise Anglade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moise Anglade. The network helps show where Moise Anglade may publish in the future.

Co-authorship network of co-authors of Moise Anglade

This figure shows the co-authorship network connecting the top 25 collaborators of Moise Anglade. A scholar is included among the top collaborators of Moise Anglade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moise Anglade. Moise Anglade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lee, Soyon, et al.. (2012). Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation. The American Journal of Cardiology. 110(6). 845–851. 108 indexed citations
2.
Lee, Soyon, et al.. (2012). COST-EFFECTIVENESS OF APIXABAN COMPARED TO ASPIRIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 59(13). E596–E596. 1 indexed citations
3.
Coleman, Craig I, et al.. (2012). Cost–Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable. The American Journal of Cardiology. 109(7). 1020–1025. 10 indexed citations
4.
Lee, Soyon, et al.. (2012). COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO WARFARIN FOR STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 59(13). E600–E600. 4 indexed citations
5.
Lee, Soyon, et al.. (2012). Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin. Circulation Cardiovascular Quality and Outcomes. 5(4). 472–479. 30 indexed citations
6.
7.
Sood, Nitesh, et al.. (2010). INTRAVENOUS CORTICOSTEROID USE IS ASSOCIATED WITH REDUCED EARLY RECURRENCE OF ATRIAL FIBRILLATION FOLLOWING RADIOFREQUENCY CATHETER ABLATION. Journal of the American College of Cardiology. 55(10). A9.E90–A9.E90. 1 indexed citations
8.
Baker, William L., et al.. (2009). A Meta-Analysis Evaluating the Impact of Chitosan on Serum Lipids in Hypercholesterolemic Patients. Annals of Nutrition and Metabolism. 55(4). 368–374. 32 indexed citations
9.
Baker, William L., Moise Anglade, Erica L Baker, et al.. (2009). Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. European Journal of Cardio-Thoracic Surgery. 35(3). 521–527. 68 indexed citations
10.
Anglade, Moise, et al.. (2007). Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study. Current Medical Research and Opinion. 23(11). 2849–2855. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel A. Sánchez-Zamorano Breakdown of academic impact, for papers by Miguel Ángel Prieto-Díaz Breakdown of academic impact, for papers by Thomas Andersen Rix Breakdown of academic impact, for papers by Isabelle Gouin Breakdown of academic impact, for papers by Chrisly Dillon Breakdown of academic impact, for papers by Alberto Calderón Breakdown of academic impact, for papers by Francisco Borrego Breakdown of academic impact, for papers by Jeroen Jaspers Focks Breakdown of academic impact, for papers by M.Á. Prieto Díaz Breakdown of academic impact, for papers by Irfan Shukrullah
Rankless by CCL
2026